electroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine
October 14, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Oct. 14, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that the company received an amended Medical...
electroCore Provides Business Update and Select Third Quarter 2021 Financial Guidance
October 12, 2021 08:00 ET
|
electroCore, Inc.
Third quarter 2021 revenue expected to be approximately $1.5 millionNet cash used to fund operations in the third quarter 2021 of approximately $3.5 million ROCKAWAY, NJ, Oct. 12, 2021 (GLOBE...
electroCore Announces Acceptance of Motion to Dismiss in the Federal Court Securities Class Action Suit
October 07, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Oct. 07, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced the granting of the company’s motion to dismiss the...
Brain Training takes Center Stage at NATO Symposium on Human Performance
October 07, 2021 08:00 ET
|
Posit Science
ROME, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Neuroscientist Dr. Michael Merzenich will be the keynote speaker on brain plasticity at a NATO symposium on Applying Neuroscience to Performance, October 11th...
electroCore Presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference
September 30, 2021 09:05 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Sept. 30, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its presentation at the...
Recognizing Tremendous Collaboration That Has 'Benefited So Many People' With Acquired Brain Injuries, Federal Judge Approves Joint Motion to Dismiss Hutchinson v. Patrick
September 29, 2021 13:47 ET
|
Brain Injury Association of Massachusetts
Westborough, Massachusetts, USA, Sept. 29, 2021 (GLOBE NEWSWIRE) -- The Brain Injury Association of Massachusetts (BIA-MA) today announced that U.S. District Court Judge Michael A. Posner has...
electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients
September 29, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Sept. 29, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the original author manuscript from the...
electroCore to Participate at Upcoming Investor Conferences
September 23, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Sept. 23, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will...
Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion
September 22, 2021 08:39 ET
|
Odyssey Group International
IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical company focused on developing unique, life-saving medical...
electroCore Announces Peter Cuneo as Board Chairman
September 20, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Sept. 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Board of Directors has appointed Peter...